Drs. Gudrun Rappold and Henning Frohlich from Heidelberg University will discuss their research on the potential benefits of a PDE10A inhibitor for individuals with FOXP1 Syndrome.
A recording may be available. Contact info@www.foxp1.org for access to the session recording or slides.